The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Diversified Healthcare Trust (NASDAQ: DHC) closed at $2.63 in the last session, down -4.36% from day before closing price of $2.75. In other words, the price has decreased by -$4.36 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
We take a closer look at DHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.50 whereas as Long-Term Debt/Eq ratio is at 1.30.
Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 13 ’24 when Brown Matthew C. bought 2,000 shares for $2.55 per share. The transaction valued at 5,098 led to the insider holds 86,282 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.42 while its Price-to-Book (P/B) ratio in mrq is 0.32.
Stock Price History:
Over the past 52 weeks, DHC has reached a high of $4.24, while it has fallen to a 52-week low of $2.01. The 50-Day Moving Average of the stock is 9.87%, while the 200-Day Moving Average is calculated to be -10.10%.
Shares Statistics:
A total of 241.27M shares are outstanding, with a floating share count of 216.65M. Insiders hold about 10.20% of the company’s shares, while institutions hold 75.62% stake in the company.
Earnings Estimates
Currently, 1.0 analysts are dedicated to thoroughly evaluating and rating the performance of Diversified Healthcare Trust (DHC) in the stock market.The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.92 and -$0.92 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.76, with 1.0 analysts recommending between -$0.76 and -$0.76.
Revenue Estimates
According to 2 analysts, the current quarter’s revenue is expected to be $374.17M. It ranges from a high estimate of $394.5M to a low estimate of $353.84M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $370.78MFor the next quarter, 2 analysts are estimating revenue of $385.79M. There is a high estimate of $414.2M for the next quarter, whereas the lowest estimate is $357.38M.
A total of 2 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.67B, while the lowest revenue estimate was $1.43B, resulting in an average revenue estimate of $1.55B. In the same quarter a year ago, actual revenue was $1.5BBased on 2 analysts’ estimates, the company’s revenue will be $1.67B in the next fiscal year. The high estimate is $1.8B and the low estimate is $1.53B.
